KraneShares Emerging Markets Healthcare Index ETF
KMED
KMED was delisted on the 18th of October, 2023.
4 hedge funds and large institutions have $250K invested in KraneShares Emerging Markets Healthcare Index ETF in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
1,289% more capital invested
Capital invested by funds: $18K → $250K (+$232K)
100% more funds holding
Funds holding: 2 → 4 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$215K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$8.77K |
| 3 |
HFA
HC Financial Advisors
Lafayette,
California
|
+$5.29K |
Top Sellers
KMED Hedge Fund Activity: Q2 2022 in Review
4 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in KraneShares Emerging Markets Healthcare Index ETF (KMED) for Q2 2022, worth a combined $250K — up 1,289% from $18K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new KMED positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $215K.
- 4 institutional investors held KraneShares Emerging Markets Healthcare Index ETF (KMED) as of Q2 2022, up from 2 in Q1 2022.
- Funds reported $250K of KraneShares Emerging Markets Healthcare Index ETF stock for Q2 2022, up 1,289% quarter-over-quarter.
- 2 funds opened new KraneShares Emerging Markets Healthcare Index ETF positions in Q2 2022 and 0 closed out, a net change of +2 holders.
- The largest KraneShares Emerging Markets Healthcare Index ETF buyer in Q2 2022 was Jane Street, an estimated $215K added.
Based on aggregated 13F filings for Q2 2022.